Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling

被引:0
|
作者
Xiaomei I. Liu
Jeremiah D. Momper
Natella Y. Rakhmanina
Dionna J. Green
Gilbert J. Burckart
Tim R. Cressey
Mark Mirochnick
Brookie M. Best
John N. van den Anker
André Dallmann
机构
[1] Children’s National Hospital,Division of Clinical Pharmacology
[2] University of California San Diego,Skaggs School of Pharmacy and Pharmaceutical Sciences
[3] Elizabeth Glaser Pediatric AIDS Foundation,Office of Pediatric Therapeutics
[4] US Food and Drug Administration,Office of Clinical Pharmacology
[5] US Food and Drug Administration,PHPT/IRD 174, Faculty of Associated Medical Sciences
[6] Chiang Mai University,Department of Immunology and Infectious Diseases
[7] Harvard T.H. Chan School of Public Health,Department of Molecular and Clinical Pharmacology
[8] University of Liverpool,Division of Pediatric Pharmacology and Pharmacometrics
[9] Boston University,undefined
[10] School of Medicine,undefined
[11] University of Basel Children’s Hospital,undefined
[12] Clinical Pharmacometrics,undefined
[13] Bayer,undefined
来源
Clinical Pharmacokinetics | 2020年 / 59卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1433 / 1450
页数:17
相关论文
共 50 条
  • [1] Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling
    Liu, Xiaomei, I
    Momper, Jeremiah D.
    Rakhmanina, Natella Y.
    Green, Dionna J.
    Burckart, Gilbert J.
    Cressey, Tim R.
    Mirochnick, Mark
    Best, Brookie M.
    van den Anker, John N.
    Dallmann, Andre
    CLINICAL PHARMACOKINETICS, 2020, 59 (11) : 1433 - 1450
  • [2] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MATERNAL-FETAL MODEL OF RALTEGRAVIR AND DOLUTEGRAVIR.
    Liu, X.
    Momper, J.
    Rakhmanina, N.
    Cressey, T.
    Mirochnick, M.
    Best, B. M.
    van den Anker, J.
    Dallmann, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S79 - S79
  • [3] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MATERNAL-FETAL MODEL OF RALTEGRAVIR AND DOLUTEGRAVIR.
    Liu, X.
    Momper, J.
    Rakhmanina, N.
    Cressey, T.
    Mirochnick, M.
    Best, B. M.
    van den Anker, J.
    Dallmann, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S104 - S105
  • [4] Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir
    Liu, Xiaomei I.
    Momper, Jeremiah D.
    Rakhmanina, Natella Y.
    Green, Dionna J.
    Burckart, Gilbert J.
    Cressey, Tim R.
    Mirochnick, Mark
    Best, Brookie M.
    van den Anker, John N.
    Dallmann, Andre
    CLINICAL PHARMACOKINETICS, 2021, 60 (06) : 795 - 809
  • [5] Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir
    Xiaomei I. Liu
    Jeremiah D. Momper
    Natella Y. Rakhmanina
    Dionna J. Green
    Gilbert J. Burckart
    Tim R. Cressey
    Mark Mirochnick
    Brookie M. Best
    John N. van den Anker
    André Dallmann
    Clinical Pharmacokinetics, 2021, 60 : 795 - 809
  • [6] Application of Physiologically Based Pharmacokinetic Modeling to Predict Raltegravir Pharmacokinetics in Children
    Zhou, Wangda
    Johnson, Trevor
    Bui, Khanh
    Cheung, S. Y. Amy
    Li, Jianguo
    Xu, Hongmei
    Al-Huniti, Nidal
    Zhou, Diansong
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 : S43 - S43
  • [7] Application of Physiologically Based Pharmacokinetic Modeling to Predict Maternal Pharmacokinetics and Fetal Exposure to Oxcarbazepine
    He, Lixia
    Ke, Meng
    Wu, Wanhong
    Chen, Jiarui
    Guo, Guimu
    Lin, Rongfang
    Huang, Pinfang
    Lin, Cuihong
    PHARMACEUTICS, 2022, 14 (11)
  • [8] Physiologically based pharmacokinetic modeling to predict maternal pharmacokinetics and fetal carbamazepine exposure during pregnancy
    Chen, Yuying
    Ke, Meng
    Fang, Weipeng
    Jiang, Yaojie
    Lin, Rongfang
    Wu, Wanhong
    Huang, Pinfang
    Lin, Cuihong
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 194
  • [9] Prediction of human CNS pharmacokinetics using a physiologically-based pharmacokinetic modeling approach
    Yamamoto, Yumi
    Valitalo, Pyry A.
    Wong, Yin Cheong
    Huntjens, Dymphy R.
    Proost, Johannes H.
    Vermeulen, An
    Krauwinkel, Walter
    Beukers, Margot W.
    Kokki, Hannu
    Kokki, Merja
    Danhof, Meindert
    van Hasselt, Johan G. C.
    de Lange, Elizabeth C. M.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 112 : 168 - 179
  • [10] Prediction of dolutegravir pharmacokinetics and dose optimization in neonates via physiologically based pharmacokinetic (PBPK) modelling
    Bunglawala, Fazila
    Rajoli, Rajith K. R.
    Mirochnick, Mark
    Owen, Andrew
    Siccardi, Marco
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (03) : 640 - 647